MYC on the Path to Cancer

Dang, Chi V.·2012·Cell

DOI 10.1016/j.cell.2012.03.003

Cited by (1,009)

Items 101–200 of 1,009

Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis
Hongli Hu, Wenwei Zhu, Jun Qin, Min Chen, Liyan Gong, Long Li, Xiangyuan Liu, Yongzhen Tao, Huiyong Yin, Hu Zhou et al. · 2016 · Hepatology
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, Chaodan Luo, Zhiwen Wang, Jin Zhang, Bo Liu · 2023 · Acta Pharmaceutica Sinica B
The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Marco Sciacovelli, Giulia Guzzo, Virginia Morello, Christian Frezza, Liang Zheng, Nazarena Nannini, Fiorella Calabrese, Gabriella Laudiero, Franca Esposito, Matteo Landriscina et al. · 2013 · Cell Metabolism
Long Noncoding RNAs in Cancer: From Function to Translation
Anirban Sahu, Udit Singhal, Arul M. Chinnaiyan · 2015 · Trends in cancer
The MYC oncogene is a global regulator of the immune response
Stephanie C. Casey, Virginie Baylot, Dean W. Felsher · 2018 · Blood
The circadian clock in cancer development and therapy
Fu, Loning, Kettner, Nicole M. · 2013 · Progress in Molecular Biology and Translational Science
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia
Marta Sánchez-Martín, Adolfo A. Ferrando · 2017 · Blood
Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms
Roman Schulte-Sasse, Stefan Budach, Denes Hnisz, Annalisa Marsico · 2021 · Nature Machine Intelligence
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Surendra Kumar Shukla, Teklab Gebregiworgis, Vinee Purohit, Nina V. Chaika, Venugopal Gunda, Prakash Radhakrishnan, Kamiya Mehla, Iraklis I. Pipinos, Robert Powers, Fang Yu et al. · 2014 · Cancer & Metabolism
MYC Oncogene Contributions to Release of Cell Cycle Brakes
Lucia García-Gutiérrez, M. Dolores Delgado, Javier León · 2019 · Genes
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
Christiane Copie‐Bergman, Peggy Dartigues, Maryse Baia, Josette Brière, Richard Delarue, Danielle Canioni, Gilles Salles, Marie Parrens, Karim Belhadj, Bettina Fabiani et al. · 2015 · Blood
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Ekaterina Rebmann Chigrinova, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Paola M. V. Rancoita, Jonathan C. Strefford, David Graham Oscier, Κώστας Σταματόπουλος, Theodora Papadaki, Françoise Berger et al. · 2013 · Blood
The nucleolus: an emerging target for cancer therapy
Nadine Hein, Katherine M. Hannan, Amee J. George, Elaine Sanij, Ross D. Hannan · 2013 · Trends in Molecular Medicine
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
Bing-Jia Chen, Yanling Wu, Yoshimasa Tanaka, Wen Zhang · 2014 · International Journal of Biological Sciences
Stemness-related markers in cancer
Xun Zhang, Wenxiu Zhao, Yvonne Y. Li · 2017 · Cancer translational medicine
A general strategy for synthesis of cyclophane-braced peptide macrocycles via palladium-catalysed intramolecular sp3 C−H arylation
Xuekai Zhang, Gang Lü, Meng Sun, Madhu Mahankali, Yanfei Ma, Mingming Zhang, Wangde Hua, Yuting Hu, Qingbing Wang, Jing‐Huo Chen et al. · 2018 · Nature Chemistry
Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells
Catarina Roma‐Rodrigues, Alexandra Ramos Fernandes, Pedro Viana Baptista · 2014 · BioMed Research International
Oncogenic Mechanisms in Burkitt Lymphoma
Roland Schmitz, Michele Ceribelli, Stefania Pittaluga, George W. Wright, Louis M. Staudt · 2014 · Cold Spring Harbor Perspectives in Medicine
Journal of Mammary Gland Biology and Neoplasia
2013 · Journal of Mammary Gland Biology and Neoplasia
The Extrinsic and Intrinsic Roles of PD‐L1 and Its Receptor PD‐1: Implications for Immunotherapy Treatment
Hudson, Katie, Cross, Neil, Jordan-Mahy, Nicola, Leyland, Rebecca · 2020 · Frontiers in Immunology
Phosphorylation-Coupled Proteolysis of the Transcription Factor MYC2 Is Important for Jasmonate-Signaled Plant Immunity
Qingzhe Zhai, Liuhua Yan, Dan Tan, Rong Chen, Jiaqiang Sun, Liyan Gao, Meng‐Qiu Dong, Yingchun Wang, Chuanyou Li · 2013 · PLoS Genetics
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells
Julia Billiard, Jennifer B. Dennison, Jacques Briand, Roland S. Annan, Deping Chai, Mariela Colón, Christopher S Dodson, Seth A. Gilbert, Joel D. Greshock, Junping Jing et al. · 2013 · Cancer & Metabolism
Emerging roles of Myc in stem cell biology and novel tumor therapies
Go J. Yoshida · 2018 · Journal of Experimental & Clinical Cancer Research
Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification
German Ott, Andreas Rosenwald, Elı́as Campo · 2013 · Blood
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Na Zhao, Jin Cao, Longyong Xu, Qianzi Tang, Lacey Elizabeth Dobrolecki, Xiangdong Lv, Manisha Talukdar, Yang Lü, Xiaoran Wang, Dorothy Zhang Hu et al. · 2018 · Journal of Clinical Investigation
The Expanding World of N-MYC–Driven Tumors
David S. Rickman, Johannes Hubertus Schulte, Martin Eilers · 2018 · Cancer Discovery
MYC and tumor metabolism: chicken and egg
Dejure, Francesca R, Eilers, Martin · 2017 · The EMBO Journal
Glutamine Metabolism in Cancer
Ting Li, Anne Le · 2018 · Advances in experimental medicine and biology
Competitive Interactions Eliminate Unfit Embryonic Stem Cells at the Onset of Differentiation
Margarida Sancho, Aida Di Gregorio, Nancy George, Sara Pozzi, Juan Miguel Sánchez, Bárbara Pernaute, Tristan A. Rodríguez · 2013 · Developmental Cell
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
Xiongwei Cai, Long Gao, Li Teng, Jingping Ge, Zaw Min Oo, Ashish R. Kumar, Dwight Gary Gilliland, Philip J. Mason, Kai Tan, Nancy A. Speck · 2015 · Cell stem cell
Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
Mohamed Elbadawy, Tatsuya Usui, Hideyuki Yamawaki, Kazuaki Sasaki · 2019 · International Journal of Molecular Sciences
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Hanna Zirath, Anna Frenzel, Ganna Oliynyk, Lova Segerström, Ulrica Westermark, Karin Larsson, Matilda Munksgaard Persson, Kjell R. Hultenby, Janne Lehtiö, Christer Einvik et al. · 2013 · Proceedings of the National Academy of Sciences
Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism
Jurian Schuijers, John C. Manteiga, Abraham S. Weintraub, Daniel S. Day, Alicia Viridiana Zamudio, Denes Hnisz, Tong Ihn Lee, Richard A. Young · 2018 · Cell Reports
Cancer Metabolism: Current Understanding and Therapies
Jessica L. Counihan, Elizabeth A. Grossman, Daniel K. Nomura · 2018 · Chemical Reviews
MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
Peng Xia, Hao Zhang, Kequan Xu, Xiang Wu Jiang, Meng Gao, Ganggang Wang, Yingyi Liu, Ye Yao, Xi Chen, Weijie Ma et al. · 2021 · Cell Death and Disease
MYC-Driven Pathways in Breast Cancer Subtypes
Yassi Fallah, Janetta Brundage, Paul Allegakoen, Ayesha N. Shajahan‐Haq · 2017 · Biomolecules
B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2
Tongguo Shi, Yanchao Ma, Lei Cao, Shenghua Zhan, Yunyun Xu, Fengqing Fu, Cuiping Liu, Guangbo Zhang, Zhenxin Wang, Ruoqin Wang et al. · 2019 · Cell Death and Disease
Targeting the nucleolus for cancer intervention
Jaclyn E. Quin, Jennifer R. Devlin, Donald P. Cameron, Kate M. Hannan, Richard B. Pearson, Ross D. Hannan · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
T cell help controls the speed of the cell cycle in germinal center B cells
Alexander D. Gitlin, Christian Thomas Mayer, Thiago Y. Oliveira, Ziv Shulman, Mathew V. Jones, Amnon Koren, Michel C. Nussenzweig · 2015 · Science
Natural course and biology of CML
Bradley Chereda, Junia V. Melo · 2015 · Annals of Hematology
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
Dey, Prasenjit, Li, Jun, Zhang, Jianhua, Chaurasiya, Surendra, Strom, Anders, Wang, Huamin, Liao, Wen-Ting, Cavallaro, Frederick, Denz, Parker, Bernard, Vincent et al. · 2020 · Cancer Discovery
PIK3CA in cancer: The past 30 years
Rand Arafeh, Yardena Samuels · 2019 · Seminars in Cancer Biology
Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development
Zhen‐Dong Xiao, Leng Han, Hyemin Lee, Li Zhuang, Yilei Zhang, Joelle Baddour, Deepak Nagrath, Christopher G. Wood, Jian Hong Gu, Xifeng Wu et al. · 2017 · Nature Communications
Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
Liangliang Shen, John M. O’Shea, Mohan Rao Kaadige, Stéphanie Cunha, Blake R. Wilde, Adam Louis Cohen, Alana L. Welm, Donald E. Ayer · 2015 · Proceedings of the National Academy of Sciences
Molecular mechanisms of natural killer cell activation in response to cellular stress
C J Chan, Mark John Smyth, Ludovic Martinet · 2013 · Cell Death and Differentiation
CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc
Shuying Shen, Yao Teng, Yining Xu, Deguang Zhang, Shunwu Fan, Jianjun Ma · 2020 · Molecular Cancer
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
Marie-Ève Beaulieu, Toni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, Peter B. Rahl, Loïka Maltais, Mariano F. Zacarías Fluck, Sílvia Casacuberta‐Serra, Erika Serrano del Pozo, Christopher Fiore et al. · 2019 · Science Translational Medicine
The pancreatic cancer genome revisited
Hayashi, Akimasa, Hong, Jungeui, Iacobuzio-Donahue, Christine A. · 2021 · Nature Reviews Gastroenterology & Hepatology
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT
Yuchao Gu, Claudio Ponte de Albuquerque, Daniel Braas, Wei Zhang, Genaro R. Villa, Junfeng Bi, Shiro Ikegami, Kenta Masui, Beatrice Gini, Huijun Yang et al. · 2017 · Molecular Cell
The Id-protein family in developmental and cancer-associated pathways
Cornelia Roschger, Chiara Cabrele · 2017 · Cell Communication and Signaling
An expanded universe of cancer targets
Hahn, William C., Bader, Joel S., Braun, Theodore P., Califano, Andrea, Clemons, Paul A., Druker, Brian J., Ewald, Andrew J., Fu, Haian, Jagu, Subhashini, Kemp, Christopher J. et al. · 2021 · Cell
Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis
Patrick A. Carroll, Daniel Diolaiti, Lisa G. McFerrin, Haiwei Gu, Danijel Djukovic, Jianhai Du, Pei Feng Cheng, Sarah Anderson, Michelle L. Ulrich, James B. Hurley et al. · 2015 · Cancer Cell
Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function
Christopher D. Scharer, Benjamin G. Barwick, Ben Youngblood, Rafi Ahmed, Jeremy M. Boss · 2013 · The Journal of Immunology
Recurrent CIC Gene Abnormalities in Angiosarcomas
Shih‐Chiang Huang, Lei Zhang, Yun‐Shao Sung, Chun‐Liang Chen, Yu‐Chien Kao, Narasimhan P. Agaram, Samuel Singer, William D. Tap, Sandra P. D’Angelo, Cristina R. Antonescu · 2016 · The American Journal of Surgical Pathology
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Omid Tavana, Dawei Li, Chao Dai, Gonzalo López, Debarshi Banerjee, Ning Kon, Chao Chen, Andrea Califano, Darrell J. Yamashiro, Hongbin Sun et al. · 2016 · Nature Medicine
METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
Peng Xia, Hao Zhang, Haofeng Lu, Kequan Xu, Xiang Wu Jiang, Yuke Jiang, Xiangdong Gongye, Zhang Chen, Jie Liu, Xi Chen et al. · 2023 · 癌症：英文版
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
Chun‐Hao Huang, Amaia Lujambio, Johannes A. Zuber, Darjus Felix Tschaharganeh, Michael G. Doran, Michael J. Evans, Thomas M. Kitzing, Nan Zhu, Elisa de Stanchina, Charles L. Sawyers et al. · 2014 · Genes & Development
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
Daniela Annibali, Jonathan Richard Whitfield, Emilia Favuzzi, Toni Jauset, Erika Serrano, Isabel Cuartas, Sara Redondo-Campos, Gerard Folch, Alba Gonzàlez-Juncà, Nicole M. Sodir et al. · 2014 · Nature Communications
The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
Arvin M. Gouw, Katherine Margulis, Natalie S. Liu, Sudha Janaki Raman, Anthony Mancuso, Georgia G. Toal, Ling Tong, Adriane R. Mosley, Annie Lee Hsieh, Delaney K. Sullivan et al. · 2019 · Cell Metabolism
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
Wanyan Wang, Jiayan Cui, Hui Ma, Weiqiang Lü, Jin Yan Huang · 2021 · Frontiers in Oncology
Targeting amino acid metabolism in cancer growth and anti-tumor immune response
Elitsa Antonova Ananieva · 2015 · World Journal of Biological Chemistry
PDK1: At the crossroad of cancer signaling pathways
Paolo Armando Gagliardi, Alberto Puliafito, Luca Primo · 2017 · Seminars in Cancer Biology
Therapeutic implications of menin inhibition in acute leukemias
Ghayas C. Issa, Farhad Ravandi, Courtney Denton Dinardo, Elias Joseph Jabbour, Hagop M. Kantarjian, Michael Andreeff · 2021 · Leukemia
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
Warren C. Fiskus, Sunil Sharma, Jun Qi, John A. Valenta, Leasha J. Schaub, Bhavin Shah, Karissa Peth, Bryce Patrick Portier, Melissa Rodríguez, Santhana G.T. Devaraj et al. · 2014 · Molecular Cancer Therapeutics
A unified model for the G1/S cell cycle transition
Samuel Hume, Grigory L. Dianov, Kristijan Ramadan · 2020 · Nucleic Acids Research
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
Arnaldur Hall, Kathrine Damm Meyle, Marina Krarup Lange, Martin Klima, May Sanderhoff, Christina Dahl, Cecilie Abildgaard, Katrine Thorup, Seyed Moein Moghimi, Per Bo Jensen et al. · 2013 · Oncotarget
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis
Liu Pin, Mengmeng Ge, Junjie Hu, Xiaolei Li, Li Che, Kun Sun, Lili Cheng, Yuedong Huang, Maria G. Pilo, Antonio Cigliano et al. · 2017 · Hepatology
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism
Angelina V. Vaseva, Devon R. Blake, Thomas S.K. Gilbert, Serina Ng, Galen H. Hostetter, Salma H. Azam, Irem Ozkan‐Dagliyan, Prson Gautam, Kirsten L. Bryant, Kenneth H. Pearce et al. · 2018 · Cancer Cell
N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger, Nicholas J. Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael A. Augello, Loredana Puca, Adnan Ahmed, Étienne Dardenne, Xiaodong Lü et al. · 2019 · Journal of Clinical Investigation
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
Dyana T. Saenz, Warren C. Fiskus, Yimin Qian, Taghi Manshouri, Kimal Rajapakshe, Kanak Raina, Kevin G. Coleman, Andrew P. A. Crew, Angela Shen, Christopher Peter Mill et al. · 2017 · Leukemia
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
Candace J. Poole, Jan van Riggelen · 2017 · Genes
Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients
Brian A. Walker, Christopher P. Wardell, Annamaria Brioli, Eileen Mary Boyle, Martin Kaiser, Dil B Begum, Nasrin B. Dahir, David C. Johnson, F. M. Ross, Faith E. Davies et al. · 2014 · Blood Cancer Journal
Mechanosensing and Mechanoregulation of Endothelial Cell Functions
Yun Hua Fang, David Wu, Konstantin G. Birukov · 2019 · Comprehensive physiology
Oncogene-Directed Alterations in Cancer Cell Metabolism
Nagarajan, Arvindhan, Malvi, Parmanand, Wajapeyee, Narendra · 2016 · Trends in Cancer
Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1
Xiaoyu Ma, Chenchen Li, Linchong Sun, De Huang, Tingting Li, Xiaoping He, Gongwei Wu, Zheng Yang, Xiuying Zhong, Libing Song et al. · 2014 · Nature Communications
BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
Baohua Sun, Warren C. Fiskus, Yimin Qian, Kimal Rajapakshe, Kanak Raina, Kevin G. Coleman, Andrew P. A. Crew, Angela Shen, Dyana T. Saenz, Christopher Peter Mill et al. · 2017 · Leukemia
The Chemical Biology of Ferroptosis in the Central Nervous System
Rajiv R. Ratan · 2020 · Cell chemical biology
MYCN Function in Neuroblastoma Development
Jörg Otte, Cecilia H. Dyberg, Adena Pepich, John Inge Johnsen · 2021 · Frontiers in Oncology
Cell Competition and Its Role in the Regulation of Cell Fitness from Development to Cancer
Aida Di Gregorio, Sarah Bowling, Tristan A. Rodríguez · 2016 · Developmental Cell
Metabolic Regulation of Apoptosis in Cancer
Kenkyo Matsuura, Kaleigh Canfield, William W. Feng, Manabu Kurokawa · 2016 · International review of cytology
Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma
Yi He, Yizhou Jing, Fang Wei, Yanyan Tang, Liting Yang, Jia Luo, Pei Yang, Qianxi Ni, Jinmeng Pang, Qianjin Liao et al. · 2018 · Cell Death and Disease
The Transcription Factor FOXM1 (Forkhead box M1)
Inken Wierstra · 2013 · Advances in cancer research
miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1
Yanqing Liu, Rui Liu, Fei Yang, Rongjie Cheng, Xiaorui Chen, Shufang Cui, Yuanyuan Gu, Wu Sun, Chaoying You, 刘志坚 et al. · 2017 · Molecular Cancer
RNA modifications and cancer
Phensinee Haruehanroengra, Ya Ying Zheng, Yubin Zhou, Yun Huang, Jia Sheng · 2020 · RNA Biology
Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
Daibiao Xiao, Ming Yue, Hexiu Su, Ping Ren, Jue Jiang, Feng Li, Yufeng Hu, Hai‐Ning Du, Hudan Liu, Guoliang Qing · 2016 · Molecular Cell
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
Carabet, Lavinia A., Rennie, Paul S., Cherkasov, Artem · 2018 · International Journal of Molecular Sciences
MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
Yulin Li, Peter S. Choi, Stephanie C. Casey, David L. Dill, Dean W. Felsher · 2014 · Cancer Cell
Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
Calabrese, David R., Chen, Xiang, Leon, Elena C., Gaikwad, Snehal M., Phyo, Zaw, Hewitt, William M., Alden, Stephanie, Hilimire, Thomas A., He, Fahu, Michalowski, Aleksandra M. et al. · 2018 · Nature Communications
Metabolic changes in cancer: beyond the Warburg effect
Wu, Weihua, Zhao, Shimin · 2013 · Acta Biochimica et Biophysica Sinica
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
Dai Horiuchi, Roman Camarda, Alicia Yiran Zhou, Christina S. F. Yau, Olga Momčilović, Sanjeev Balakrishnan, Alexandra N. Corella, Henok Eyob, Kai Kessenbrock, Devon A. Lawson et al. · 2016 · Nature Medicine
Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling
Cyril Corbet, Olivier Féron · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Protein Amounts of the MYC Transcription Factor Determine Germinal Center B Cell Division Capacity
Shlomo Finkin, Harald Hartweger, Thiago Y. Oliveira, Ervin E. Kara, Michel C. Nussenzweig · 2019 · Immunity
An integrative ENCODE resource for cancer genomics
Zhang, Jing, Lee, Donghoon, Dhiman, Vineet, Jiang, Peng, Xu, Jie, McGillivray, Patrick, Yang, Hongbo, Liu, Jason, Meyerson, William, Clarke, Declan et al. · 2020 · Nature Communications
Metabolic rewiring in melanoma
Boris I. Ratnikov, David A. Scott, Andrei L. Osterman, Jeffrey W. Smith, Ze’ev A. Ronai · 2016 · Oncogene
Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells
Antonella F. M. Dost, Aaron Lavel Moye, Marall Vedaie, Linh My Tran, Eileen Fung, Dar M. Heinze, Carlos Villacorta-Martín, Jessie Huang, Ryan Matthew Hekman, Julian Kwan et al. · 2020 · Cell stem cell
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles
Eejung Kim, Nina Ilić, Yashaswi Shrestha, Lihua Zou, Atanas Kamburov, Cong Zhu, Xiaoping Yang, Rakela Lubonja, Nancy H. Tran, Cindy Nguyen et al. · 2016 · Cancer Discovery
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
Fangyan Gao, Xin-tong Li, Kun Xu, Runtian Wang, Xiaoxiang Guan · 2023 · Cell Communication and Signaling
MYC: a complex problem
Subhendu Das, Brian A. Lewis, David Levens · 2022 · Trends in Cell Biology
Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas
Clémentine Sarkozy, Alexandra Traverse‐Glehen, Bertrand Coiffier · 2015 · The Lancet Oncology
A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses
Susanne Heinzel, Tran Binh Giang, Andrey Kan, Julia M. Marchingo, Bryan Lye, Lynn M. Corcoran, Philip D. Hodgkin · 2016 · Nature Immunology